Ipca Labs inks pact to acquire Ramdev Chemical for Rs 108.5 cr

By: |
April 24, 2019 9:36 PM

RCPL is engaged in manufacturing and marketing of advanced drug intermediates, fine chemicals, custom synthesis molecules and active pharmaceutical ingredients (APIs).

Ipca Labs inks pact to acquire Ramdev Chemical for Rs 108.5 crIpca Labs inks pact to acquire Ramdev Chemical for Rs 108.5 cr

Drug firm Ipca Laboratories Wednesday said it has entered into a pact to buy Maharashtra-based Ramdev Chemical for Rs 108.5 crore.

The company has entered into a share purchase agreement (SPA) to acquire 100 per cent paid-up share capital of Ramdev Chemical Pvt Ltd (RCPL), Ipca Laboratories said in a regulatory filing.

RCPL is engaged in manufacturing and marketing of advanced drug intermediates, fine chemicals, custom synthesis molecules and active pharmaceutical ingredients (APIs).

The acquisition will help the company grow its API business by adding new molecules with possibility of forward integrating such products in its dosage formulations business for the global markets, it added.

RCPL’s registered office and manufacturing unit is located in the Palghar district of Maharashtra.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1DLF sale bookings up 24% at Rs 3,084 cr in FY21
2Claims of Co-WIN system hacking, data leak ‘baseless’: Govt
3This Indian developer’s ‘innovation’ just won Apple’s prestigious design award